Kingsview Wealth Management, LLC Bristol Myers Squibb CO Call Options Transaction History

Kingsview Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $5,482 - $6,409	100 Added 50.0%	300 $1,000
Q3 2019 Jan 29, 2020	SELL	$42.77 - $50.71 $25,662 - $30,426	-600 Reduced 75.0%	200 $1,000
Q2 2019 Jan 29, 2020	BUY	$44.62 - $49.34 $22,310 - $24,670	500 Added 166.67%	800 $0
Q3 2018 Jan 29, 2020	SELL	$55.19 - $62.25 $546,381 - $616,275	-9,900 Reduced 97.06%	300 $1,000
Q2 2017 Jan 29, 2020	BUY	N/A	10,200	10,200 $1,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kingsview Wealth Management, LLC with notifications on news.